Impact of glucagon-like peptide-1 on myocardial glucose metabolism revisited

Medicine & Life Sciences

• Glucagon-Like Peptide 1 100%
• Dipeptidyl-Peptidase IV Inhibitors 56%
• Glucose 53%
• Incretins 36%
• Glucagon-Like Peptides 21%
• Dipeptidyl Peptidase 4 19%
• Health Care Outcome Assessment 18%
• Glucagon-Like Peptide-1 Receptor 18%
• Stroke Volume 12%
• Blood Glucose 11%
• Atherosclerosis 11%
• Perfusion 10%
• Ischemia 10%
• Type 2 Diabetes Mellitus 10%
• Cardiovascular Diseases 10%
• Body Weight 10%
• Hormones 10%
• Clinical Studies 9%
• Blood Pressure 9%
• Safety 8%
• Enzymes 7%
• Therapeutics 4%